GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearmind Medicine Inc (XCNQ:CMND) » Definitions » ROC (Joel Greenblatt) %

Clearmind Medicine (XCNQ:CMND) ROC (Joel Greenblatt) % : -152,088.89% (As of Oct. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Clearmind Medicine ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Clearmind Medicine's annualized ROC (Joel Greenblatt) % for the quarter that ended in Oct. 2023 was -152,088.89%.

The historical rank and industry rank for Clearmind Medicine's ROC (Joel Greenblatt) % or its related term are showing as below:

XCNQ:CMND' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -31270.27   Med: -1479.15   Max: -61.76
Current: -31270.27

During the past 7 years, Clearmind Medicine's highest ROC (Joel Greenblatt) % was -61.76%. The lowest was -31270.27%. And the median was -1479.15%.

XCNQ:CMND's ROC (Joel Greenblatt) % is ranked worse than
96.6% of 1470 companies
in the Biotechnology industry
Industry Median: -338.875 vs XCNQ:CMND: -31270.27

Clearmind Medicine's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -230.80% per year.


Clearmind Medicine ROC (Joel Greenblatt) % Historical Data

The historical data trend for Clearmind Medicine's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearmind Medicine ROC (Joel Greenblatt) % Chart

Clearmind Medicine Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial -61.76 -232.68 -2,679.60 -17,860.00 -24,717.65

Clearmind Medicine Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8,540.74 -22,472.73 -24,996.23 -42,019.05 -152,088.89

Competitive Comparison of Clearmind Medicine's ROC (Joel Greenblatt) %

For the Biotechnology subindustry, Clearmind Medicine's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clearmind Medicine's ROC (Joel Greenblatt) % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clearmind Medicine's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Clearmind Medicine's ROC (Joel Greenblatt) % falls into.



Clearmind Medicine ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jul. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.151) - (0.348 + 0 + 1.313)
=-1.51

Working Capital(Q: Oct. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.040999999999999) - (0.659 + 0 + 4.311)
=-4.929

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Clearmind Medicine for the quarter that ended in Oct. 2023 can be restated as:

ROC (Joel Greenblatt) %(Q: Oct. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jul. 2023  Q: Oct. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-6.844/( ( (0.007 + max(-1.51, 0)) + (0.002 + max(-4.929, 0)) )/ 2 )
=-6.844/( ( 0.007 + 0.002 )/ 2 )
=-6.844/0.0045
=-152,088.89 %

Note: The EBIT data used here is four times the quarterly (Oct. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clearmind Medicine  (XCNQ:CMND) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Clearmind Medicine ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Clearmind Medicine's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Clearmind Medicine (XCNQ:CMND) Business Description

Traded in Other Exchanges
Address
101-1220 West 6th Avenue, Vancouver, BC, CAN, V6H 1A5
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Clearmind Medicine (XCNQ:CMND) Headlines

From GuruFocus